Activiomics, a life sciences firm spun out from Queen Mary University of London, has been acquired by virology research company Retroscreen Virology Group for £4m ($6.7m).
Retroscreeen, itself a spin-out from Queen Mary incorporated in 1988, is also issuing up to £4m in new ordinary shares at 5p per share to support the deal.
The acquisition is part of a strategy to build Retroscreen’s testing and data analytical capabilities, supported by a £25.5m venture round last year. The UK-based firm…